Literature DB >> 3629423

The role of surgery in N2 lung cancer.

N Martini, B J Flehinger.   

Abstract

Whereas most physicians believe that long-term survival is unlikely when mediastinal lymph node metastases are present, a significant number of these patients do have resectable tumors with encouraging long-term survival results. Data are presented to support this view, and steps identified to guide the physicians in selecting the patients who can benefit from this surgical approach.

Entities:  

Mesh：

Year:  1987        PMID： 3629423     DOI： 10.1016/s0039-6109(16)44341-0

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  42 in total

1.  [Postoperative radiotherapy in curatively resected non-small-cell bronchial carcinoma].

Authors:  H T Klages; M Stuschke
Journal:  Strahlenther Onkol       Date:  1999-03       Impact factor: 3.621

2.  The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer.

Authors:  P Goldstraw
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

3.  Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.

Authors:  Honghai Dai; Zhouguang Hui; Wei Ji; Jun Liang; Jima Lu; Guangfei Ou; Zongmei Zhou; Qinfu Feng; Zefen Xiao; Dongfu Chen; Hongxing Zhang; Weibo Yin; Jie He; Luhua Wang
Journal:  Oncologist       Date:  2011-04-11

Review 4.  Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.

Authors:  R Milroy; F Macbeth
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

Review 5.  Surgical management of lung cancer.

Authors:  Adam Lackey; Jessica S Donington
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 6.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

7.  Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer.

Authors:  Min Kyu Kang; Yong Chan Ahn; Do Hoon Lim; Keunchil Park; Joon Oh Park; Young Mog Shim; Jhingook Kim; Kwhanmien Kim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

8.  Changes in hemodynamics in patients who underwent extended mediastinal lymphadenectomy through median sternotomy for primary lung cancer.

Authors:  Tomomi Hirata; Kiyoshi Koizumi; Shigeo Tanaka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-05

9.  Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer.

Authors:  Kazuhiro Ueda; Yoshikazu Kaneda; Hisashi Sakano; Toshiki Tanaka; Masatarou Hayashi; Tao-Sheng Li; Kimikazu Hamano
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-07

10.  Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients.

Authors:  Jing Li; Chun-Hua Dai; Shun-Bing Shi; Ping Chen; Li-Chao Yu; Jian-Rong Wu
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.